Metropolitan Life Insurance CO Opti Nose, Inc. Transaction History
Metropolitan Life Insurance CO
- $252 Million
- Q4 2024
Shares
8 transactions
Others Institutions Holding OPTN
# of Institutions
9Shares Held
52.9MCall Options Held
0Put Options Held
0About OptiNose, Inc.
- Ticker OPTN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 83,277,504
- Market Cap $500M
- Description
- OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...